AIM Letters & Comments

AIM letter to members and partners on the end of the COVID-19 Public Health Emergency.

On December 20, 2022, Congress released a final FY 2023 spending bill that includes a $31 million increase for the CDC’s Section 317 Immunization Program.

AIM provided comments on the Vaccines Federal Implementation Plan (VFIP). AIM commented on four key areas using lessons learned during the COVID-19 pandemic.

AIM provided public comment on the Proposed Changes and Proposed Measurement Retirements to the Adult Immunization Status Measure (AIS-E).

AIM and the National Association of School Nurses (NASN) are excited to share the NASN School Nurse January 2022 Special Supplement “School-Located Vaccination (SLV) Clinics in the Era of COVID-19.”

AIM Policy Consultant Brent Ewig, AIM Executive Director Claire Hannan, and ASTHO CEO Michael Fraser on COVID-19 vaccination and what lies ahead.

AIM joined with several other immunization stakeholders to urge Congress to include the Protecting Seniors Through Immunization Act in the Build Back Better package.

Since the beginning of pandemic, immunization program managers have been working long days, nights, and weekends to address the many challenges of vaccinating the nation. The success and impact of this vaccine campaign are nothing short of miraculous.

Association of State and Territorial Health Officials and AIM's letter in support of emergency supplemental funding dedicated to a national vaccination program.

The key to COVID vaccination success moving forward is increased supply, increased transparency and communication, and most importantly, increased collaboration. Federal, state and local public health must work together, not in competition, united by the same vision and goals.

Consistent and accurate vaccine allocations and projections are needed for planning, and strong communication with the public about what is happening and what they can expect.